Karyopharm Therapeutics Inc.
KPTI
13 insider filings · Latest: May 21, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 15 4:08 PM | Stuart PoultonEVP, Chief Development Officer | Sale | 403 | $9.50 | $3.8K | 94,821(D) | View → |
| May 14, 2026 | May 15 4:07 PM | Reshma RangwalaEVP & Chief Medical Officer | Sale | 408 | $9.50 | $3.9K | 56,829(D) | View → |
| May 14, 2026 | May 15 4:05 PM | Sohanya Roshan ChengEVP & Chief Commercial Officer | Sale | 324 | $9.50 | $3.1K | 107,940(D) | View → |
| May 14, 2026 | May 15 4:04 PM | Kristin AbateChief Accounting Officer | Sale | 53 | $9.50 | $504 | 23,801(D) | View → |
| May 14, 2026 | May 15 4:03 PM | Richard A. PaulsonDirector, President and CEO | Sale | 2,203 | $9.50 | $20.9K | 269,747(D) | View → |
| May 14, 2026 | May 15 4:02 PM | Michael ManoEVP, CLO&Secretary | Sale | 266 | $9.50 | $2.5K | 94,398(D) | View → |
| Apr 21, 2026 | Apr 22 4:03 PM | Reshma RangwalaEVP & Chief Medical Officer | Sale | 449 | $8.94 | $4.0K | 56,290(D) | View → |
Stock Options & Derivatives
No transactions found.